New study tests if switching arthritis and IBD injections hurts less
NCT ID NCT05913817
First seen Mar 28, 2026 · Last updated Apr 29, 2026 · Updated 6 times
Summary
This study looked at whether switching from a low-concentration to a high-concentration adalimumab injection (AVT-02) causes less pain at the injection site. It included 324 adults with conditions like Crohn's disease, rheumatoid arthritis, and psoriasis. Researchers measured pain using a simple scale and tracked how well patients stuck with the new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
JAMP Pharma Corporation
Montreal, Quebec, J4B 5H3, Canada
Conditions
Explore the condition pages connected to this study.